Related Experiment Video
Updated: Dec 7, 2025

07:10
An Ex Vivo Tissue Culture Model of Cartilage Remodeling in Bovine Knee Explants
Published on: November 3, 2019
9.6K
Hyperosmolar Ionic Solutions Modulate Inflammatory Phenotype and sGAG Loss in a Cartilage Explant Model
Ahmad S Arabiyat1,2, Hongyu Chen1,2, Josh Erndt-Marino3
1Department of Biomedical Engineering, Rensselaer Polytechnic Institute (RPI), Troy, NY, USA.
Cartilage
|September 25, 2020
Summary
Lithium chloride (LiCl) reduced osteoarthritis (OA) markers and cartilage damage in stimulated explants, unlike potassium chloride (KCl). These findings suggest hyperosmolar ionic solutions may offer novel OA treatments.
Area of Science:
- Biochemistry
- Orthopedics
- Pharmacology
Background:
- Osteoarthritis (OA) is a degenerative joint disease characterized by cartilage breakdown and inflammation.
- Tumor necrosis factor-alpha (TNF-α) is a key pro-inflammatory cytokine implicated in OA pathogenesis.
- Sulfated glycosaminoglycan (sGAG) loss is a critical indicator of cartilage degradation in OA.
Purpose of the Study:
- To compare the effects of hyperosmolar sodium (Na+), lithium (Li+), and potassium (K+) on OA markers and sGAG loss.
- To investigate the impact of these ions on TNF-α-stimulated cartilage explants.
Main Methods:
- Bovine stifle joint cartilage explants were stimulated with TNF-α to induce degradation.
- Explants were treated with hyperosmolar solutions of LiCl, KCl, NaCl, or dexamethasone.
- sGAG loss and expression of OA-associated proteins (ADAMTS-5, COX-2, MMP-1, MMP-13, VEGF) were assessed.
Main Results:
- TNF-α stimulation increased sGAG loss and expression of COX-2, MMP-13, and VEGF.
- LiCl and dexamethasone attenuated sGAG loss and MMP-13 expression.
- KCl exacerbated sGAG loss and MMP-1 expression, while NaCl had no significant effect.
Conclusions:
- Different ionic species induce varying responses in TNF-α-stimulated cartilage.
- LiCl demonstrated a potent reduction in catabolic and inflammatory mediators compared to KCl.
- Hyperosmolar ionic solutions warrant further investigation for potential intra-articular OA therapies.

